• Biomea Fusion launched an underwritten public offering of common stock, with pre-funded warrants available in lieu of common shares.
• All securities in the deal will be sold by Biomea.
• Underwriter to receive a 30-day option to buy up to 15% additional shares of common stock or pre-funded warrants.
• Pricing, size, timing remain subject to market conditions.
• Konik Capital Partners to act as sole underwriter.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biomea Fusion Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609221605PRIMZONEFULLFEED9831831) on September 22, 2026, and is solely responsible for the information contained therein.